Biotech · Public company · San Diego, CA, US

ARS Pharmaceuticals, Inc.

Ticker SPRY · SEC CIK 0001671858

Track this companyFree. Adds ARS Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials42 recruiting or active

Pipeline programs8From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline8

An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaPHASE2 · RECRUITING · started Jul 9, 2025ClinicalTrials.gov NCT06927999 · fetched Nov 12, 2026
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen ImmunotherapyPHASE4 · RECRUITING · started May 20, 2025ClinicalTrials.gov NCT06834165 · fetched Nov 12, 2026
Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaPHASE2 · COMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT05363670 · fetched Nov 12, 2026
Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria FlaresPHASE2 · COMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT05496465 · fetched Nov 12, 2026